Analyst firms · Vertical Research · APD
Vertical Research APD price target and rating history
Air Products and Chemicals Inc. (APD) · Basic Materials
Vertical Research rates Air Products and Chemicals Inc. (APD) Buy with a $336 price target, as of its latest action on Oct 7, 2024. It has published 4 rating actions on APD since January 2022, including 3 upgrades and 1 downgrade. Across 7 firms with a APD price target in the last 12 months, the median target is $325.
- Current rating
- Buy
- Price target
- $336
- Median target, all firms
- $325
- Actions on APD
- 4
Vertical Research price target on APD
Every Vertical Research rating on APD
- Oct 7, 2024
- Mar 13, 2023
- Jan 4, 2023
- Jan 4, 2022
How other firms rate APD
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Barclays | Overweight | $353 | Oct 13, 2026 |
| KeyBanc Capital Markets | Sector Weight | Sep 11, 2026 | |
| BMO Capital Markets | Outperform | $360 | May 1, 2026 |
| Berenberg | Buy | $350 | Apr 20, 2026 |
| Wells Fargo | Overweight | $325 | Mar 13, 2026 |
| BofA Securities | Neutral | $275 | Jan 8, 2026 |
| Citigroup | Neutral | $245 | Dec 15, 2025 |
| UBS | Neutral | $250 | Dec 12, 2025 |
Questions about Vertical Research and APD
- What is Vertical Research's price target for APD?
- Vertical Research's latest stated price target for Air Products and Chemicals Inc. (APD) is $336, from its action on Oct 7, 2024.
- What is Vertical Research's rating on APD?
- Vertical Research rates APD Buy, a bullish rating, as of Oct 7, 2024.
- When did Vertical Research last change its view on APD?
- On Oct 7, 2024, Vertical Research upgrades to Buy from Hold, price target $336.
- How does Vertical Research's APD target compare with other analysts?
- Across 7 firms with a APD price target in the last 12 months, the median target is $325.
More APD rating histories
All Vertical Research ratingsAPD news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.